Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4Phase 1/2 2Phase 1 1

Status

Completed 4Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5Genitourinary 1

Conditions

Fallopian Tube Neoplasms 5Ovarian Neoplasms 4Carcinoma, Ovarian Epithelial 3Neoplasms 2Recurrence 1Prostatic Neoplasms 1Pathologic Complete Response 1Metastatic Castration Resistant Prostate Cancer 1Genital Neoplasms, Male 1Adenocarcinoma, Clear Cell 1

Interventions

Paclitaxel 45Carboplatin 33Bevacizumab 17liposomal doxorubicin 15Topotecan 12Taxes 10Gemcitabine 10Drug Therapy 6Cisplatin 6rucaparib 5mirvetuximab soravtansine 5Docetaxel 5Immunoglobulin G 4Doxorubicin 4Disulfides 4trebananib 3pembrolizumab 3olaparib 3Saline Solution 3Neoadjuvant Therapy 3Hyperthermic Intraperitoneal Chemotherapy 3Dexamethasone 3CP protocol 3niraparib 2cediranib 2Tamoxifen 2Specimen Handling 2Letrozole 2Glucose 2Cytoreduction Surgical Procedures 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Fallopian Tube Neoplasms × rucaparib × Clear all
NCT03522246 2025-06-24

ATHENA

pharmaand GmbH

Phase 3 Active not recruiting
1,097 enrolled 26 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Pathologic Complete Response, Fallopian Tube Neoplasms, Neoplasms

NCT04227522 2024-11-15

MAMOC

North Eastern German Society of Gynaecological Oncology

Phase 3 Completed
42 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Adenocarcinoma, Clear Cell

NCT04676334 2024-05-07

CATCH-R

pharmaand GmbH

Phase 3 Completed
34 enrolled 9 charts
GenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Genital Neoplasms, Male, Ovarian Neoplasms, Prostatic Neoplasms

NCT01968213 2023-06-09

ARIEL3

pharmaand GmbH

Phase 3 Completed
564 enrolled 18 charts 1 FDA
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02855944 2023-06-09

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

pharmaand GmbH

Phase 3 Completed
349 enrolled 29 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡